← All Sponsors
SPONSOR

Shu Peng

Total Trials
1
Recruiting
1
Phases
N/A
Conditions studied: Esophageal Cancer
NCT07354295
Recruiting

Integrating Multimodal AI to Predict Treatment Response and Refine Risk Stratification in Esophageal Cancer （Radiogenomics-Esophagus）

Esophageal Cancer
China View Trial →